Clinical significance of antiphospholipid nephropathy in systemic lupus erythematosus.

被引:0
|
作者
Jara, LJ [1 ]
机构
[1] IMSS, Mexico City, DF, Mexico
来源
ARTHRITIS AND RHEUMATISM | 2005年 / 52卷 / 09期
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:S383 / S384
页数:2
相关论文
共 50 条
  • [1] Prognostic significance of antiphospholipid nephropathy in systemic lupus erythematosus
    Miranda-Limón, JM
    Estevez, A
    Calleja, C
    Saavedra-Salinas, MA
    Jara, LJ
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2005, 64 : 99 - 99
  • [2] The impact of antiphospholipid syndrome nephropathy on renal outcomes in systemic lupus erythematosus.
    Williams, ESA
    Lum, RF
    Olson, JL
    Criswell, LA
    [J]. ARTHRITIS AND RHEUMATISM, 2003, 48 (09): : S358 - S359
  • [3] Clinical significance of antiphospholipid syndrome nephropathy (APSN) in patients with systemic lupus erythematosus (SLE)
    Miranda, Juan M.
    Jara, Luis J.
    Calleja, Concepcion
    Saavedra, Miguel A.
    Bustamante, Reyna M.
    Angeles, Ulises
    [J]. REUMATOLOGIA CLINICA, 2009, 5 (05): : 209 - 213
  • [4] Antiphospholipid syndrome in children with systemic lupus erythematosus.
    Campos, LMMA
    Liphaus, BL
    Silva, CAA
    Kiss, MHB
    [J]. ARTHRITIS AND RHEUMATISM, 2000, 43 (09): : S322 - S322
  • [5] The clinical significance of antiphospholipid antibodies in systemic lupus erythematosus
    Unlu, Ozan
    Zuily, Stephane
    Erkan, Doruk
    [J]. EUROPEAN JOURNAL OF RHEUMATOLOGY, 2016, 3 (02) : 75 - 84
  • [6] Systemic lupus erythematosus.: Antiphospholipid syndrome -: Mucocutaneous manifestations of systemic lupus
    Francés, C
    Crickx, B
    Beylot, C
    [J]. ANNALES DE DERMATOLOGIE ET DE VENEREOLOGIE, 2002, 129 (10): : S102 - S105
  • [7] Antiphospholipid syndrome nephropathy in systemic lupus erythematosus
    Daugas, E
    Nochy, D
    Huong, DLT
    Duhaut, P
    Beaufils, H
    Caudwell, V
    Bariety, J
    Piette, JC
    Hill, G
    [J]. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2002, 13 (01): : 42 - 52
  • [8] Clinical trials in systemic lupus erythematosus.
    Buyon J.P.
    [J]. Current Rheumatology Reports, 2000, 2 (1) : 11 - 12
  • [9] Clinical significance of neuropsychiatric events at the time of diagnosis of systemic lupus erythematosus.
    Hanly, J. G.
    Urowitz, M. B.
    Sanchez-Guerrero, J.
    Bae, S-C
    Gordon, C.
    Wallace, D. J.
    Isenberg, D.
    Alarcon, G.
    Clarke, A.
    Bernatsky, S.
    Merrill, J. T.
    Petri, M.
    Dooley, M. A.
    Gladman, D.
    Fortin, P. R.
    Steinsson, K.
    Bruce, I.
    Manzi, S.
    Khamashta, M.
    Zoma, A.
    Aranow, C.
    Ginzler, E.
    Van Vollehnoven, R.
    Font, J.
    Sturfelt, G.
    Nived, O.
    Ramsey-Goldman, R.
    Kalunian, K.
    Douglas, J.
    Thompson, K.
    Farewell, V.
    [J]. ARTHRITIS AND RHEUMATISM, 2006, 54 (09): : S274 - S274
  • [10] Lupus erythematosus. Antiphospholipid syndrome
    Aractingi, S.
    Aubin, F.
    Avril, M. -F.
    Bachelez, H.
    Bagot, M.
    Barbaud, A.
    Basset-Seguin, N.
    Beani, J. -C.
    Bedane, C.
    Berard, F.
    Berbis, P.
    Bernard, P.
    Beylot-Barry, M.
    Bodemer, C.
    Bonnetblanc, J. -M.
    Boralevi, F.
    Bourgault-Villada, I.
    Cambazard, F.
    Carsuzaa, F.
    Caux, F.
    Chevrant-Breton, J.
    Chosidow, O.
    Claudy, A.
    Couppie, P.
    Cribier, B.
    Crickx, B.
    Delaporte, E.
    Dereure, O.
    Descamps, V.
    Doutre, M. -S.
    Dreno, B.
    Dupin, N.
    Faure, M.
    Frances, C.
    Grange, F.
    Grob, J. -J.
    Guillet, G.
    Guillot, B.
    Rabia, S. Hadj
    Humbert, P.
    d'Incan, M.
    Joly, P.
    Jullien, D.
    Lacour, J. -P.
    Laroche, L.
    Lebbe, C.
    Leccia, M. -T.
    Leroy, D.
    Lipsker, D.
    Lok, C.
    [J]. ANNALES DE DERMATOLOGIE ET DE VENEREOLOGIE, 2012, 139 (11): : A102 - A111